China Health Tech calls Sept. 29 shareholder meeting after requisition seeks board overhaul

• China Health Technology Group scheduled an extraordinary general meeting for Sept. 29, 2026, following a shareholder requisition filed Sept. 2.
• The requisition seeks to remove all six incumbent directors, including chair Bi Xue and CEO Leung Ka Wai, effective at the meeting’s close.
• It also proposes appointing four new directors, including two independent non-executive directors, leaving the board short of Hong Kong’s minimum requirement.
• The requisitioning shareholder, Lin Yudan, held at least 10% of voting rights when the notice was submitted.
• The board noted no reasons were provided for the overhaul, urging shareholders to weigh governance and operational implications before voting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Health Technology Group Holding Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260910-12328506), on September 10, 2026, and is solely responsible for the information contained therein.